Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

T-VEC

A drug used to treat melanoma that has recurred (come back) after surgery. It is used in patients whose cancer is in the skin and lymph nodes and cannot be removed by surgery. It is also being studied in the treatment of other types of cancer. T-VEC is made with a form of the herpesvirus that has been changed in the laboratory to infect and break down cancer cells without harming normal cells. It may also help the immune system kill cancer cells. T-VEC is injected directly into tumors in the skin and lymph nodes. It is a type of oncolytic virus therapy. Also called Imlygic and talimogene laherparepvec.
More Information
Search NCI's Dictionary of Cancer Terms